Table VI.
Timea | n | N | R | PH | R/PH | P-value |
---|---|---|---|---|---|---|
2 | 5 | 0.161±0.014 | 0.185±0.060 | 0.166±0.080 | 0.150±0.022 | 0.032 |
3 | 5 | 0.164±0.004 | 0.178±0.090 | 0.219±0.040 | 0.186±0.110 | 0.019 |
4 | 5 | 0.155±0.090 | 0.193±0.040 | 0.323±0.010 | 0.254±0.040 | 0.006 |
7 | 5 | 0.182±0.012 | 0.189±0.030 | 0.290±0.037 | 0.343±0.010 | <0.001 |
14 | 5 | 0.156±0.010 | 0.168±0.015 | 0.241±0.020 | 0.534±0.050 | <0.001 |
21 | 5 | 0.161±0.030 | 0.175±0.011 | 0.154±0.045 | 0.507±0.010 | <0.001 |
30 | 5 | 0.155±0.060 | 0.180±0.020 | 0.152±0.020 | 0.536±0.028 | <0.001 |
P-value | 0.48 | 0.52 | <0.001 | <0.001 |
Days post-PH. Data are presented as the mean ± standard deviation. There was no significant difference among the time points of the N group (P>0.05). N, normal control group; R, retrorsine-treated group; PH, partial hepatectomy; R/PH, retrorsine-treated plus PH group.